HEPPAR1 and PIWIL2 as Panel Markers for Hepatocellular Carcinoma

Bibliographic Information
Authors: Hammad G.; Magdy M.; Aboushousha T.; Abdelraouf A.; Mamdouh S.
Journal: Asian Pacific Journal of Cancer Prevention
Publisher: Asian Pacific Organization for Cancer Prevention
Publication Date: 1 June 2024
Volume / Issue: Volume 25 / Issue 6
Pages: 2123–2131
ISSN: 15137368
DOI: 10.31557/APJCP.2024.25.6.2123
Scopus: View on Scopus
PubMed: 38918675
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
Hammad G., Faculty of Biotechnology, October University for Modern Sciences & Arts (MSA), Giza, Egypt; Magdy M., Department of Pathology, Theodor Bilharz Research Institute, (TBRI), Giza, Egypt; Aboushousha T., Department of Pathology, Theodor Bilharz Research Institute, (TBRI), Giza, Egypt; Abdelraouf A., Department of Hepatobiliopancreatic Surgery, National Hepatology and Tropical Medicine Research Institute, (NHTMRI), Cairo, Egypt; Mamdouh S., Department of Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Giza, Egypt
Abstract
Objective: The aim of this study was to evaluate the expression profiles of PIWI-like protein- 2 (PIWIL2), and HepPar1 and their immunohistochemical (IHC) characteristics in Hepatocellular Carcinoma (HCC), and determine their correlation with clinicopathological parameters of this type of cancer to determine their diagnostic value in combination. Methods: Seventy-five patients with HCC were assessed for the expression of PIWIL2 in serum and tissue using real-time polymerase chain reaction (RT-PCR) and IHC was performed for PIWIL2 and HepPar1 was performed on all patients. Results: A statistically significantly higher level of PIWIL2 was found in HCC compared to controls (p≤0.001). Both HepPar1 and PIWIL2 were detected in 84% of HCC cases, the diagnostic and prognostic factors for PIWIL2 were found to be significant in liver tumour tissue samples and non-tumorous sections p<0.001, and the same was observed for serum samples and results of healthy serum controls (p<0.001) when compared to AFP. Conclusion: Our results affirm the hypothesis that reactivation of PIWI expression in various caner types is crucial for cancer development, and that a possible panel maybe used for these markers HCC diagnosis. © (2024), (Asian Pacific Organization for Cancer Prevention). All rights reserved.
Keywords
Diagnosis; HCC; HEPPAR1; PIWIL2; Prognosis; RT-QPCR; Adult; Aged; alpha-Fetoproteins; Argonaute Proteins; Biomarkers, Tumor; Carcinoma, Hepatocellular; Case-Control Studies; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; alpha fetoprotein; argonaute protein; PIWIL2 protein, human; tumor marker; blood; case control study; follow up; genetics; human; liver cell carcinoma; liver tumor; metabolism; pathology
Citation Information
Scopus Citations: 1
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
